IM Cannabis Corp (NASDAQ:IMCC), a Canadian medical cannabis provider, released its Q3 2023 financial figures on Monday, disclosing revenue of CA$12.4 million ($8.99 million) down by 13% compared to the third quarter of 2022.
Q3 2023 Financial Highlights
- Revenue saw a 13% decrease, totaling CA$12.4 million.
- Net Loss from Continuing Operations was CA$2.1 million, compared to CA$4.5 million in the third quarter of 2022.
- Adjusted EBITDA loss in the third quarter of 2023 was CA$1.3 million, a decrease of 65% compared to the third quarter …